Christopher L. Kramer

Dysautonomia in Guillain–Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes

Tia Chakraborty, Christopher L. Kramer, Eelco F. M. Wijdicks et al. · Neurocritical Care · 2019 · 120 citations

Clinical Disorders, Neurological Disorder, Diagnosis +4

Heparin‐binding epidermal growth factor‐like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome

Christopher L. Kramer, Kai Klasmeyer, Hans Bojar et al. · Cancer · 2007 · 60 citations

Asymptomatic Carotid Stenosis: Risk of Progression and Development of Symptoms

Tarun D. Singh, Christopher L. Kramer, Jay Mandrekar et al. · Cerebrovascular Diseases · 2015 · 25 citations

Severe Relapse of Vaccine-Induced Guillain–Barré Syndrome After Treatment With Nivolumab

Carlen Yuen, David Kamson, Betty Soliven et al. · Journal of Clinical Neuromuscular Disease · 2019 · 25 citations

Immunodeficiencies, Immunology, Pathology +18

Neurologist Versus Machine: Is the Pupillometer Better than the Naked Eye in Detecting Pupillary Reactivity

Christopher L. Kramer, Alejandro A. Rabinstein, Eelco F. M. Wijdicks et al. · Neurocritical Care · 2014 · 24 citations

Cognitive Science, Ophthalmology, Physiological Optic +9